TABLE 1.

Baseline Characteristics of the Study Population

	Study Population (N = 44)
Age, years	59.2 ± 11.7 (37–81)
Female sex	27 (61.4)
Caucasian race	36 (81.8)
Baseline A1C, %	9.7 ± 1.6
Weight, lb	222.2 ± 17.1
BMI, kg/m2	36.3 ± 9.5
Insulin TDD, units	86 ± 46.4
Patients on oral medications	31 (70.5)
Patients on GLP-1 receptor agonist therapy	4 (9)

Data are mean ± SD or n (%) except for age, which is mean ± SD (range).